Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1

Human immunodeficiency virus type 1 (HIV-1)-infected individuals who develop drug-resistant virus during antiretroviral therapy may derive benefit from continued treatment for two reasons. First, drug-resistant viruses can retain partial susceptibility to the drug combination. Second, therapy select...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Zhang, Haili, Zhou, Yan, Alcock, Cecily, Kiefer, Tara, Monie, Daphne, Siliciano, Janet, Li, Quan, Pham, Paul, Cofrancesco, Joseph, Persaud, Deborah, Siliciano, Robert F.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2004
Assuntos:
Vaccines and Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC369469/
https://ncbi.nlm.nih.gov/pubmed/14747537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.4.1718-1729.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares